Safety and Efficacy of Berodual® Inhaled Via Respimat® Compared to MDI (Metered Dose Inhaler) in Pediatric Patients With Asthma

Condition:   Asthma
Interventions:   Drug: Berodual® Respimat®, low dose;   Drug: Berodual® Respimat®, high dose;   Drug: Berodual® MDI
Sponsor:   Boehringer Ingelheim
Completed – verified July 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days